Recent Updates
Recently added Catalysts
DTIL Positive Sentiment

Precision BioSciences Presents Preclinical Data Highlighting the Capability of ARCUS for High-Efficiency Gene Editing Utilizing Homology-Directed Repair at the ESGCT 31st Annual Congress

Key Takeaway: Precision BioSciences presented preclinical data at the ESGCT 31st Annual Congress, showcasing the capabilities of the ARCUS gene editing platform. The ARCUS approach utilizes homology-directed repair (HDR) to achieve high-efficiency gene editing, potentially allowing for a wider range of therapeutic applications compared to existing methods. This technology could be particularly beneficial for diseases requiring a gain in function.
Price reaction · baseline $6.5 (2024-11-21 close) · hit pre-market · 5 other DTIL headline(s) in the window, move may be shared
day 0 close · peak
+11.7%
day 1
+11.4%
day 3
+9.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • ARCUS approach offers broader therapeutic potential.
  • High-efficiency gene editing could lead to significant advancements.
  • Homology-directed repair allows for precise gene insertion.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
4.8%
average across 2 past catalysts
Cash runway
~19 mo
Low dilution risk
Lead asset
Targeted CEA CAR-T
Phase 1 · Advanced Lung Cancer

Full Press Release Details

– Stimulating gene editing by homology-directed repair (HDR) has the potential advantage of being able to achieve any type of edit, including gene insertion – ARCUS approach potentially offers broader therapeutic than current gene editing modalities for diseases that require a gain in function

Frequently Asked Questions

What is the ARCUS gene editing approach?

The ARCUS approach utilizes homology-directed repair for high-efficiency gene editing.

What advantages does ARCUS offer over other methods?

ARCUS potentially provides broader therapeutic applications than current gene editing modalities.

Where was the ARCUS data presented?

The data was presented at the ESGCT 31st Annual Congress.

What type of edits can ARCUS achieve?

ARCUS can achieve various edits, including gene insertion.

Last updated: Nov 22, 2024